-
For Consumers
-
Resources for You
-
-
Hepatitis B and C
What's New at FDA in Hepatitis
Late breaking information, as well as an archival record of updates on safety and regulatory issues related to Hepatitis A and B, including
- product approvals
- significant labeling changes
- safety warnings
- notices of upcoming public meetings
- notices about proposed regulatory guidances
Hepatitis updates by e-mail
You can get updates about drug approvals, drug safety updates and other issues related to hepatitis by joining the FDA Hepatitis List Serve.
Viral Hepatitis Therapies
Approved therapies for treatment of Hepatitis B and C
-
2009
- New class safety labeling updates for alpha interferon products
- New Rules for Expanded Access to Investigational Drugs for Treatment Use and Charging for Investigational Drugs
- Dose adjustments of PegIntron and Rebetol for certain patients with chronic hepatitis C
- Important information about Hydroxycut dietary supplement products
- Approval of new oral solution of Tyzeka for treatment of chronic hepatitis B (HBV)
-
Contact Us
Office of Special Health Issues
- 301.827.4460
- OSHI@oc.fda.gov
5600 Fishers Lane
HF-12, Room 9-49
Rockville, MD 20857
-
-
-